Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration

被引：0
|
作者：
Salih Uzun
Emre Pehlivan
机构：
[1] Etimesgut Military Hospital,Department of Ophthalmology
[2] Etimesgut Asker Hastanesi Goz Hastaliklari Servisi,Department of Ophthalmology
[3] Eskisehir Military Hospital,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2016年 / 254卷
关键词：
Ranibizumab; Aflibercept; Choroidal Thickness; Ranibizumab Injection; Subfoveal Choroidal Thickness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2065 / 2066
页数：1
相关论文
共 50 条
  • [21] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [22] Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
    Unlu, Cihan
    Erdogan, Gurkan
    Gunay, Betul Onal
    Akcay, Betul Ilkay Sezgin
    Kardes, Esra
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (04) : 849 - 851
  • [23] Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for neovascular age-related macular degeneration
    Cihan ünlü
    Gurkan Erdogan
    Betul Onal Gunay
    Betul Ilkay Sezgin Akcay
    Esra Kardes
    International Journal of Ophthalmology, 2015, (04) : 849 - 851
  • [24] Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration
    Mazaraki, Kyriaki
    Fassnacht-Riederle, Heidi
    Blum, Robert
    Becker, Matthias
    Michels, Stephan
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (10) : 1341 - 1344
  • [25] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [26] VISUAL AND ANATOMIC OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Fung, Adrian T.
    Kumar, Nishant
    Marsiglia, Marcela
    Mrejen, Sarah
    Slakter, Jason
    Sorenson, John
    Freund, K. Bailey
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 51 - 51
  • [27] VISUAL AND ANATOMICAL OUTCOMES OF INTRAVITREAL AFLIBERCEPT IN EYES WITH PERSISTENT SUBFOVEAL FLUID DESPITE PREVIOUS TREATMENTS WITH RANIBIZUMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kumar, Nishant
    Marsiglia, Marcela
    Mrejen, Sarah
    Fung, Adrian Tien-Chin
    Slakter, Jason
    Sorenson, John
    Freund, K. Bailey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (08): : 1605 - 1612
  • [28] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
  • [29] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [30] Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema
    Unlu, Cihan
    Erdogan, Gurkan
    Gunay, Betul Onal
    Kardes, Esra
    Akcay, Betul Ilkay Sezgin
    Ergin, Ahmet
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 147 - 158
12345